Nitric oxide and ionizing radiation synergistically promote apoptosis and growth inhibition of cancer by activating p53

Cancer Research

Volumn 64, Issue 21, 2004, Pages 8015-8021

  Cook, Tracy ^a   Wang, Zifa ^a   Alber, Sean ^a   Liu, Kaihong ^a   Watkins, Simon C ^a   Vodovotz, Yoram ^a   Billiar, Timothy R ^a   Blumberg, David ^a  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INDUCIBLE NITRIC OXIDE SYNTHASE; NITRIC OXIDE; PROTEIN P53; SERINE;

ANIMAL MODEL; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; COLORECTAL CANCER; CONTROLLED STUDY; GENE TRANSFER; HUMAN; HUMAN CELL; IONIZING RADIATION; MOUSE; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; TUMOR;

ADENOVIRIDAE; ANIMALS; APOPTOSIS; CELL LINE, TUMOR; COLONIC NEOPLASMS; COMBINED MODALITY THERAPY; GENE THERAPY; HUMANS; MICE; MICE, NUDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; RADIATION TOLERANCE; TUMOR SUPPRESSOR PROTEIN P53;

EID: 7444243914     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-04-2212     Document Type: Article

References (44)

1. Blumberg D, Ramanathan RK. Treatment of colon and rectal cancer. J Clin Gastroenterol 2002;34:15-26.
2. Quirke P, Durdey P, Dixon MF, Williams NS. Local recurrence of rectal adenocarcinoma due to inadequate surgical resection. Histopathological study of lateral tumour spread and surgical excision. Lancet 1986;2:996-9.
3. Minsky BD, Cohen AM, Enker WE, Sigurdson E. Phase I/II trial of pre-operative radiation therapy and coloanal anastomosis in distal invasive resectable rectal cancer. Int J Radiat Oncol Biol Phys 1992;23:387-92.
4. Hyams DM, Mamounas EP, Petrelli, N. A clinical trial to evaluate the worth of preoperative multimodality therapy in patients with operable carcinoma of the rectum: a progress report of National Surgical Adjuvant Breast and Bowel Project Protocol R-03. Dis Colon Rectum 1997;40:131-9.
5. Mehta VK, Poen J, Ford PS, et al. Radiotherapy, concomitant protracted-venous infusion 5-fluoro-uracil, and surgery for ultrasound-staged T3 or T4 rectal cancer. Dis Colon Rectum 2001;44:52-8.
6. Read TE, McNevin EKM, Gross HM, et al. Neoadjuvant therapy for adenocarcinoma of the rectum: tumor response and acute toxicity. Dis Colon Rectum 2001;44:513-22.
7. Meade PG, Blatchford GJ, Thorson MA, et al. Preoperative chemoradiation down-stages locally advanced ultrasound-staged rectal cancer. Am J Surg 1995;170:609-13.
8. Bouzourene H, Bosman FT, Seelentag M, et al. Importance of tumor regression assessment in predicting the outcome in patients with locally advanced rectal carcinoma who are treated with preoperative radiotherapy. Cancer (Phila) 2002;94:1121-30.
9. 2 tension measurements. Cancer Res 1991;51:6098-102.
10. Krishna MC, English S, Yamada K, et al. Overhauser enhanced magnetic resonance imaging for tumor oximetry: coregistration of tumor anatomy and tissue oxygen concentration. Proc Natl Acad Sci USA 2002;99:2216-21.
11. Yang B, Keshleva N, Anderson CP, Reynolds CP. Antagonism of buthionine sulfoximine cytotoxicity for human neuroblastoma cell lines by hypoxia is reversed by the bioreductive agent tirapazamine. Cancer Res 2003;63:1520-6.
12. Howard-Flanders P. Effect of nitric oxide on the radiosensitivity of bacteria. Nature (Lond) 1957;180:1191-2.
13. Dewey DL. Effect of oxygen and nitric oxide on the radiosensitivity of human cells in tissue culture. Nature (Lond) 1960;186:780-2.
14. Xie K, Huang S, Dong Z, et al. Transfection with the inducible nitric oxide synthase gene suppresses tumorigenicity and abrogates metastasis by K-1735 murine melanoma cells. J Exp Med 1995;181:1333-43.
15. Kurimoto M, Endo S, Hiroshima H, Ogiichi T, Takaku A. Growth inhibition and radiosensitization of cultured glioma cells by nitric oxide generating agents. J Neurooncol 1999;42:35-44.
16. Mitchell JB, Wink DA, DeGraff W, et al. Hypoxic mammalian cell radiosensitization by nitric oxide. Cancer Res 1993;53:5845-8.
17. Griffin RJ, Makepeace CM, Hur WJ, Song CW. Radiosensitizing of hypoxic tumor cells in vitro by nitric oxide. Int J Radiat Oncol Biol Phys 1996;36:377-83.
18. Jordan BF, Misson PD, Demeure R, et al. Changes in tumor oxygenation/perfusion induced by the NO donor, isosorbide dinitrate, in comparison with carbogen: monitoring by EPR and MRI. Int J Radial Oncol Biol Phys 2000;48:565-70.
19. Mitchell JB, DeGraff W, Kim S, et al. Redox generation of nitric oxide to radiosensitize hypoxic cells. Int J Radial Oncol Biol Phys 1998;42:795-8.
20. Chung P, Cook T, Liu K, et al. Overexpression of the human inducible nitric oxide synthase gene enhances radiation-induced apoptosis in colorectal cancer cells via a caspase-dependent mechanism. Nitric Oxide 2003;8:119-26.
21. Soler MN, Bobe P, Benihoud K, et al. Gene therapy of rat medullary thyroid cancer by naked nitric oxide synthase II DNA injection. J Gene Med 2000;2:344-52.
22. Khare PD, Liao S, Hirose Y, et al. Specifically targeted killing of carcinoembryonic antigen (CEA)-expressing cells by a retroviral vector displaying single-chain variable fragmented antibody to CEA and carrying the gene for inducible nitric oxide synthase. Cancer Res 2001;61:370-5.
23. Xu W, Liu L, Charles IG. Microencapsulated iNOS-expressing cells cause tumor suppression in mice. FASEB J 2002;16:213-5.
24. Worthington J, Robson T, O'Keefe M, Hirst DG. Tumor cell radiosensitization using constitutive (CMV) and radiation inducible (WAF1) promoters to drive the iNOS gene: a novel suicide gene therapy. Gene Ther 2002;9:263-9.
25. Wang Z, Cook T, Alber S, et al. Adenoviral gene transfer of the human inducible nitric oxide synthase gene enhances the radiation resistance of human colorectal cancer associated with alterations. Cancer Res 2004;64:1386-95.
26. Schneiderhan N, Budde A, Zhang Y, Brune B. Nitric oxide induces phosphorylation of p53 and impairs nuclear export. Oncogene 2003;22:2857-68.
27. Chao C, Saito S, Anderson CW, Appella E, Xu Y. Phosphorylation of murine p53 at Ser-18 regulates the p53 responses to DNA damage. Proc Natl Acad Sci USA 2000;97:11936-41.
28. Unger T, Sionov RV, Moallem E, et al. Mutations in serines 15 and 20 of human p53 impair its apoptotic activity. Oncogene 1999;18:3205-12.
29. Abraham J, Spaner D, Benchimol S. Phosphorylation of the p53 protein in response to ionizing radiation occurs at multiple sites in both normal and DNA-PK deficient cells. Oncogene 1999;18:1521-7.
30. Ambs S, Merriam WG, Ogunfusika MO, et al. p53 and vascular endothelial growth factor regulate tumor growth of NOS2-expressing human carcinoma cells. Nat Med 1998;4:1371-6.
31. Finkelstein SD, Przygodzki RM, Pricolo VE, et al. Prediction of biological aggressiveness in colorectal cancer by p53/K-ras-2 topographic genotyping. Molecular Diagnosis 1996;1:5-28.
32. Hofseth LJ, Saito S, Hussain SP, et al. Nitric oxide-induced cellular stress and p53 activation in chronic inflammation. Proc Natl Acad Sci USA 2003;100:143-8.
33. Del Bino G, Darzynkiewicz Z, Degraef C, et al. Comparison of methods based on annexin-V binding, DNA content or TUNEL for evaluating cell death in HL-60 and adherent MCF-7 cells. Cell Prolif 1999;32:25-37.
34. Lawrence TS, Davis MA, Hough A, Rehemtulla A. The role of apoptosis in 2′2′-difluoro-2′-deoxycytidine (gemcitabine)-mediated radiosensitization. Clin Cancer Res 2001;7:314-9.
35. waf/cip1 antisense therapy radiosensitizes human colon cancer by converting growth arrest to apoptosis. Cancer Res 2000;60:679-84.
36. Kuninaka S, Ichinose Y, Koja K, Toh Y. Suppression of manganese superoxide dismutase augments the sensitivity to radiation, hyperthermia and doxorubicin in colon cancer cell lines by inducing apoptosis. Br J Cancer 2000;83:928-34.
37. Brooks CL, Gu W. Ubiquitination, phosphorylation and acetylation: the molecular basis for p53 regulation. Curr Opin Cell Biol 2003;15:164-71.
38. Zhang Y, Xiong Y. A p53 amino-terminal nuclear export signal inhibited by DNA damage-induced phosphorylation. Science (Wash DC) 2001;292:1910-5.
39. Jaiswal M, LaRusso NF, Shapiro RA, Billiar TR, Gores GJ. Nitric oxide-mediated inhibition of DNA repair potentiates oxidative DNA damage in cholangiocytes. Gastroenterology 2001;120:190-9.
40. Zurer I, Hofseth LJ, Cohen Y, et al. The role of p53 in base excision repair following genotoxic stress. Carcinogenesis (Lond) 2004;25:11-9.
41. Scherr DS, Vaughan ED Jr, Wei J, et al. BCL-2 and p53 expression in clinically localized prostate cancer predicts response to external beam radiotherapy. J Urol 1999;162:12-6.
42. Bristow RG, Benchimol S, Hill RP, et al. The p53 gene as a modifier of intrinsic radiosensitivity: implications for radiotherapy. Radiother Oncol 1996;40:197-223.
43. Spitz FR, Nguyen D, Skibber JM, et al. Adenoviral-mediated wild-type p53 gene expression sensitizes colorectal cancer cells to ionizing radiation. Clin Cancer Res 1996;2:1665-71.
44. Lang FF, Yung WK, Raju U, et al. Enhancement of radiosensitivity of wild-type p53 human glioma cells by adenovirus-mediated delivery of the p53 gene. J Neurosurg 1998;89:125-32.